|
CN112168187A
|
|
Diagnostic index, diagnostic model and diagnostic system for schizophrenia
|
|
CN111505288A
|
|
Novel depression biomarker and application thereof
|
|
CN111489822A
|
|
Therapeutic drug monitoring result interpretation system
|
|
CN110646626A
|
|
Use of 24-hydroxycholesterol in the manufacture of a product for the diagnosis or early diagnosis of schizophrenia
|
|
CN110988369A
|
|
Application of 27-hydroxycholesterol in preparation of antidepressant drug efficacy-related products
|
|
CN110702929A
|
|
Use of 27-hydroxycholesterol in the manufacture of a product for diagnosing schizophrenia
|
|
CN110702930A
|
|
Application of 24-hydroxycholesterol in preparation of depression diagnosis and treatment related products
|
|
CN110988351A
|
|
Application of vascular cell adhesion molecule in preparation of depression diagnosis and treatment related products
|
|
CN110702917A
|
|
Application of serum amyloid P in preparation of products related to depression diagnosis and treatment
|
|
CN109781977A
|
|
IL15R α and related membrane protein detection kit and its application
|
|
CN109223006A
|
|
A kind of schizophrenia diagnosis system
|
|
CN109480866A
|
|
A method of utilizing pupillometry PPI
|
|
CN109473170A
|
|
Schizoid system is diagnosed using cognition index
|
|
CN109199413A
|
|
A kind of system using pupillometry PPI
|
|
CN109119161A
|
|
A kind of schizoid diagnostic model
|
|
CN109480864A
|
|
A kind of schizophrenia automatic evaluation system based on nervous functional defects and machine learning
|
|
CN109480865A
|
|
Schizoid system is diagnosed using eye movement index
|
|
CN109346178A
|
|
Schizoid model is diagnosed based on cognitive function
|
|
CN107345970A
|
|
A kind of peripheral blood biomarker available for Schizophrenia diagnosis
|
|
CN108732355A
|
|
A kind of active detection method of measurement BACE1 digestions NRG1 and its kit
|
